Invention Grant
- Patent Title: Glycan-interacting compounds and methods of use
-
Application No.: US16489569Application Date: 2018-03-02
-
Publication No.: US11253609B2Publication Date: 2022-02-22
- Inventor: Daniel T. Dransfield , Jillian M. Prendergast , David A. Eavarone
- Applicant: Seagen Inc.
- Applicant Address: US WA Bothell
- Assignee: Seagen Inc.
- Current Assignee: Seagen Inc.
- Current Assignee Address: US WA Bothell
- Agency: McNeill Baur PLLC
- International Application: PCT/US2018/020562 WO 20180302
- International Announcement: WO2018/160909 WO 20180907
- Main IPC: A61K31/337
- IPC: A61K31/337 ; A61K31/44 ; A61K31/4745 ; A61K31/506 ; A61K31/513 ; A61K31/519 ; A61K31/7068 ; A61K33/243 ; A61K38/08 ; A61P35/00 ; A61K47/68 ; A61K9/00 ; A61K39/395 ; C07K16/30 ; A61K39/00
Abstract:
Methods of treating cancer are provided that include administering glycan-interacting antibodies. Included are anti-sialyl Tn antigen antibodies and related compositions and formulations suitable to achieve desirable bioactivity, bioavailability, and toxicity levels.
Public/Granted literature
- US20200000932A1 GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE Public/Granted day:2020-01-02
Information query
